Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

James Forman appointed CEO and president of flavors and fragrance supplier as company moves beyond integration phase into preparing for an initial public offering within the next three to four years, Holzminden, Germany firm reports Sept. 15. Effective Oct. 1, Forman will succeed Horst-Otto Gerberding, who will become vice chairman of the board. Gerberding's role as CEO and president was intended as an interim position during the integration phase of the Dragoco and Haarmann & Reimer businesses (1"The Rose Sheet" Oct. 14, 2002, In Brief). Gerberding will continue to help oversee the company's strategic direction and position it for the IPO. Forman most recently served as CEO of consumer products company Stollwerck AG...

You may also be interested in...

Symrise CEO

Gerold Linzbach to CEO effective March 1, succeeding James Forman, who has stepped down by mutual agreement, Holzminden, Germany flavors and fragrance supplier announces Feb. 11. Linzbach, who previously served as president of Invista Resins & Fibers in the U.S., will benefit Symrise with his extensive experience in strategic realignment, the firm notes. Exec assumes role as company moves to expand its global business and further strengthen its relationship with clients, according to Symrise. Forman led the company through its final phase of integration following its creation by the 2002 merger of Dragoco and Haarmann & Reimer (1"The Rose Sheet" Sept. 22, 2003, In Brief)...

H&R/Dragoco management

Combined fragrance and flavors businesses, acquired by Swedish EQT Northern Europe Equity Funds, will be headed by Horst-Otto Gerberding as CEO, firm says following close of transaction Oct. 1. Among other management team appointments, Dan Stebbins will be in charge of flavors, while Tim Schaffner will head fragrances and cosmetics. Horst Finkelmeier will oversee aroma chemicals, Heinz-Jurgen Bertram will be in charge of R&D, Jurgen Nienhaus is named head of operations, and Martin Wolf is chief financial officer. Merger received clearance from European Commission in September (1"The Rose Sheet" Sept. 23, 2002, In Brief)...

QUOTED. 20 February 2020. Steven Raman.

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts